Abstract:4701 Introduction : Inflammatory breast carcinoma (IBC), a particularly aggressive orphan cancer accounts for 1-6% of all invasive breast tumors with rather poor prognosis. The ability to characterize IBC based on molecular signatures will greatly facilitate the rational development of novel therapeutic strategies targeting key signaling pathways involved in growth/survival of IBC cells. RhoC GTPase, a member of the Ras superfamily of small GTPases, has been reported to be overexpressed in 90% of IBC tumors versus 38% of stage matched, non-IBC tumors. The enzyme, isoprenylcysteine carboxyl methyltransferase (Icmt) involved in prenylation of the Ras superfamily proteins plays a critical role in oncogenic transformation. Previous published studies in colon cancer cells have shown that treatment with a novel small molecule inhibitor (cysmethynil) targeting Icmt resulted in mislocalization of Ras, inhibition of anchorage independent growth, and impaired epidermal growth factor signaling. Therefore, the objectives of this study are 1. Characterize IBC cell lines and establish an imageable IBC tumor model to identify critical dysregulated pathways 2. Characterization of a small GTPases-specific small molecule inhibitor in the IBC models. Results: The growth kinetics in serum and serum-free media have been optimized for the various human SUM IBC cell lines. Further the SUM 149 and 159 cell lines have been established to express luciferase reporter gene driven by a constitutive CMV promoter. Retrovirus-packaging cell line Psi-X-Ampho were transfected with luciferase-reporter plasmid by the use of Lipofectamine reagent for the packaging of replication-deficient retrovirus. The infected SUM cells were selected for the expression of the desired luciferase gene by adding puromycin in cell culture medium. The Icmt small molecule inhibitor, cysmethynil, is being tested in the parent and luciferase expressing SUM cell lines and compared with non-IBC cell lines. Preliminary studies reveal a dose- and time-dependent inhibition of IBC cell proliferation in the presence of cysmethynil, as assessed by MTT assays. Immunoblot analysis of the cell lysates revealed a specific downregulation of Rho proteins on day 4 post cysmethynil treatment. Conclusion: Currently, in addition to understanding the mechanism of Rho inhibition in the IBC cells, we are also generating other imageable IBC cell lines. There are few IBC models and these luciferase cell lines will be extremely useful not only for characterization and exploration of the molecular signatures of human IBC but also for quantitative analysis and in vivo non-invasive imaging in tumor models.

Fluorescent tagging of endogenous IRS2 with an auxin-dependent degron to assess dynamic intracellular localization and function

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer

Insulin-like Growth Factor I Receptor Signaling and Nuclear Translocation of Insulin Receptor Substrates 1 and 2.

The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint

Role of IRS-2 in insulin and cytokine signalling

Abstract P2-26-13: Gene deletion of insulin receptor in MCF-7L breast cancer cells by CRISPR gene editing

Labeling Endogenous Proteins Using CRISPR-mediated Insertion of Exon (CRISPIE)

Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore

Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action

Interaction Between Nuclear Insulin Receptor Substrate-2 and NF-κB in IGF-1 Induces Response in Breast Cancer Cells.

Depletion of Insulin Receptor Substrate 2 Reverses Oncogenic Transformation Induced by V-Src

Irs-2, but Not Irs-1, Can Sustain Proliferation and Rescue Ubf Stabilization in Inr or Inr Defective Signaling of 32d Myeloid Cells

CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting

Insulin receptor substrate 1 is a novel member of EGFR signaling in pancreatic cells

Quantifying small GTPase activation status using a novel fluorescence HPLC-based assay

Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition

Development of Cellular Models and Small Gtpases-Targeted Therapeutics for Inflammatory Breast Cancer

Targeting the Insulin Growth Factor-1 Receptor with Fluorescent Antibodies Enables High Resolution Imaging of Human Pancreatic Cancer in Orthotopic Mouse Models

Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells

Regulation of Insulin Receptor Substrate‐1 Expression Levels by Caveolin‐1

Small molecule-nanobody conjugate induced proximity controls intracellular processes and modulates endogenous unligandable targets